Several reasons lead to the selection of RIOK1 as the target for further investigation, including that RIOK1 was found to be overexpressed in colon cancer cells, which promotes cell proliferation in vitro in human CRC [24,48]. Here, RIOK1 is linked to malignant colon neoplasm.